Search research articles
Contact Us
Filters
Showing results (11-20 of 52) with videos related to
Page
of 6
Sort By:
Current Gene Therapy
|
April 10, 2009
Hepatic delivery of RNA interference activators for therapeutic application
Patrick Arbuthnot, Abdullah Ely, Marc S Weinberg
Expert Opinion on Biological Therapy
|
December 22, 2017
How successful has targeted RNA interference for hepatic fibrosis been?
Mohube Betty Maepa, Abdullah Ely, Patrick Arbuthnot
Advanced Drug Delivery Reviews
|
June 3, 2020
In vitro transcribed mRNA for expression of designer nucleases: Advantages as a novel therapeutic for the management of chronic HBV infection
Abdullah Ely, Prashika Singh, Tiffany S Smith, et al.
Genes
|
April 13, 2018
Gene Therapy for Chronic HBV-Can We Eliminate cccDNA?
Kristie Bloom, Mohube Betty Maepa, Abdullah Ely, et al.
Gene Therapy
|
November 18, 2024
Bridging gene therapy and next-generation vaccine technologies
Kristie Bloom, Abdullah Ely, Mohube Betty Maepa, et al.
International Journal of Molecular Sciences
|
August 13, 2015
Progress and Prospects of Anti-HBV Gene Therapy Development
Mohube B Maepa, Ilke Roelofse, Abdullah Ely, et al.
Molecular Therapy. Nucleic Acids
|
June 19, 2017
Sustained Inhibition of HBV Replication In Vivo after Systemic Injection of AAVs Encoding Artificial Antiviral Primary MicroRNAs
Mohube Betty Maepa, Abdullah Ely, Wayne Grayson, et al.
Biomed Research International
|
July 9, 2014
Inhibition of hepatitis B virus replication by helper dependent adenoviral vectors expressing artificial anti-HBV pri-miRs from a liver-specific promoter
Mohube Betty Mowa, Carol Crowther, Abdullah Ely, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
February 2, 2020
Generating DNA Expression Cassettes Encoding Multimeric Artificial MicroRNA Precursors
Fiona T van den Berg, Abdullah Ely, Patrick Arbuthnot
Microrna (Shariqah, United Arab Emirates)
|
July 23, 2014
Efficient silencing of hepatitis B virus by helper-dependent adenovirus vector-mediated delivery of artificial antiviral primary micro RNAs
Mohube B Mowa, Carol Crowther, Abdullah Ely, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 52) with videos related to
Sort By:
Page
of 6
Current Gene Therapy
|
April 10, 2009
Hepatic delivery of RNA interference activators for therapeutic application
Patrick Arbuthnot, Abdullah Ely, Marc S Weinberg
Expert Opinion on Biological Therapy
|
December 22, 2017
How successful has targeted RNA interference for hepatic fibrosis been?
Mohube Betty Maepa, Abdullah Ely, Patrick Arbuthnot
Advanced Drug Delivery Reviews
|
June 3, 2020
In vitro transcribed mRNA for expression of designer nucleases: Advantages as a novel therapeutic for the management of chronic HBV infection
Abdullah Ely, Prashika Singh, Tiffany S Smith, et al.
Genes
|
April 13, 2018
Gene Therapy for Chronic HBV-Can We Eliminate cccDNA?
Kristie Bloom, Mohube Betty Maepa, Abdullah Ely, et al.
Gene Therapy
|
November 18, 2024
Bridging gene therapy and next-generation vaccine technologies
Kristie Bloom, Abdullah Ely, Mohube Betty Maepa, et al.
International Journal of Molecular Sciences
|
August 13, 2015
Progress and Prospects of Anti-HBV Gene Therapy Development
Mohube B Maepa, Ilke Roelofse, Abdullah Ely, et al.
Molecular Therapy. Nucleic Acids
|
June 19, 2017
Sustained Inhibition of HBV Replication In Vivo after Systemic Injection of AAVs Encoding Artificial Antiviral Primary MicroRNAs
Mohube Betty Maepa, Abdullah Ely, Wayne Grayson, et al.
Biomed Research International
|
July 9, 2014
Inhibition of hepatitis B virus replication by helper dependent adenoviral vectors expressing artificial anti-HBV pri-miRs from a liver-specific promoter
Mohube Betty Mowa, Carol Crowther, Abdullah Ely, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
February 2, 2020
Generating DNA Expression Cassettes Encoding Multimeric Artificial MicroRNA Precursors
Fiona T van den Berg, Abdullah Ely, Patrick Arbuthnot
Microrna (Shariqah, United Arab Emirates)
|
July 23, 2014
Efficient silencing of hepatitis B virus by helper-dependent adenovirus vector-mediated delivery of artificial antiviral primary micro RNAs
Mohube B Mowa, Carol Crowther, Abdullah Ely, et al.
Page
of 6